BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2140331)

  • 1. Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis.
    Fraschini F
    J Int Med Res; 1990; 18(2):171-6. PubMed ID: 2140331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of clarithromycin versus josamycin in the treatment of hospitalized patients with bacterial pneumonia.
    Straneo G; Scarpazza G
    J Int Med Res; 1990; 18(2):164-70. PubMed ID: 2140330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis.
    Guay DR; Craft JC
    J Intern Med; 1992 Mar; 231(3):295-301. PubMed ID: 1532615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarithromycin in the treatment of bacterial relapses of chronic bronchitis.
    Dericoloso A; Sanduzzi A; Cuccurullo S; Sarno M; Bianco A; Moro RA
    Riv Eur Sci Med Farmacol; 1991; 13(5-6):275-83. PubMed ID: 1840282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
    Bradbury F
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():153-62. PubMed ID: 8396087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Azithromycin versus josamycin: treatment of 89 cases of acute pneumonia].
    Aprim ; Brion JP; Sedallian A; Le Noc P; Briffod J; Micoud M
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):521-5. PubMed ID: 2166934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Hosie J; Quinn P; Smits P; Sides G
    J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis.
    Gaillat J
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():139-51. PubMed ID: 8478305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
    J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis.
    Bachand RT
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():91-100. PubMed ID: 1827107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis.
    Ziering W; McElvaine P
    Infection; 1998; 26(1):68-75. PubMed ID: 9505188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drugs--reports of new drugs recently approved by the FDA. Dirithromycin.
    Shinkai I; Ohta Y
    Bioorg Med Chem; 1996 Apr; 4(4):521-2. PubMed ID: 8735838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
    Daniel R
    J Int Med Res; 1991; 19(5):373-83. PubMed ID: 1660824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
    Fogarty C; de Wet R; Mandell L; Chang J; Rangaraju M; Nusrat R
    Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis.
    Sides GD
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():131-8. PubMed ID: 8478304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.
    Wasilewski MM; Johns D; Sides GD
    J Antimicrob Chemother; 1999 Apr; 43(4):541-8. PubMed ID: 10350384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerance of erythromycin acistrate in the treatment of acute exacerbations of chronic bronchitis in the elderly.
    Forsén KO; Wikberg R; Lehtonen L
    Chemotherapy; 1993; 39(6):443-52. PubMed ID: 8222874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Josamycin in the treatment of bronchopulmonary infections.
    Lozano R; Balaguer A
    Clin Ther; 1991; 13(2):281-8. PubMed ID: 1863943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarithromycin in the treatment of community-acquired lower respiratory tract infections.
    Anderson G
    J Hosp Infect; 1991 Sep; 19 Suppl A():21-7. PubMed ID: 1684979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.